Fundraising Fox

1955 CapitalFull Portfolio

13 tracked investments · listed companies and verified rows first

Acuamark Dxacuamarkdx.comin

AcuamarkDx is a molecular diagnostics company developing early cancer detection technology using proprietary qPCR and machine learning-driven assays for cancer screening and recurrence monitoring.

AI & Machine LearningBiotechDigital HealthHealthtechMedical Devices

Bernard Peperstraete(Co-Founder & CEO)

Ampaireampaire.comin𝕏Jul 2018

Ampaire develops hybrid-electric propulsion systems for aircraft, with the AmpDrive technology deployed across multiple aircraft types to reduce fuel consumption, maintenance costs, and noise emissions.

CleantechClimate TechEnergyHardwareSpace TechLos Angeles, US

Kevin Noertker(Executive Officer, Director)Cory Combs(Executive Officer, Director)Ryan Bilton(Executive Officer, Director)

Co-investorsAutodesk FoundationHemisphere Ventures LLCTechstarsMassive

Craifcraif.cominOct 2021

Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.

AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP

Ryuichi Onose(Executive Officer, Director)inYuki Ichikawa(Director)Mika Yui(Director)

Co-investorsGlobal BrainAozora Corporate Investment

Crop Enhancementcrop-enhancement.com

Crop Enhancement develops CropCoat, a nontoxic crop treatment that leaves no residue on the harvested crop, aimed at agricultural growers.

AgTechNew Materials

Co-investorsBandgap VenturesPhoenix Venture PartnersSpruce Capital Partners

Gridtentialgridtential.comJan 2016

Combining cost & safety of lead-acid and performance & lifetime of Li-ion

Santa Clara, US

Christiaan W Beekhuis(Executive Officer, Director)

BoardDan Miller(Director)Roger Strauch(Director)inMichele Klein(Director)Ray Kubis(Director)

Co-investorsThe Roda Group

Nature's Fyndnaturesfynd.com

The Fynder Group develops a biotechnology platform using extremophile fungi to produce specialty ingredients, biopharmaceutical drugs, and bio-based materials for food, beverage, pharmaceutical, and textile applications.

BiotechFoodTechNew MaterialsChicago, US

Matthew Strongin(Founder)in

Co-investorsBreakthrough Energy VenturesDanone Manifesto VentureLauder PartnersSoftBank Vision Fund

Noahmednoahmed.comin𝕏

Noah Medical develops the Galaxy System, a robotic bronchoscopy platform that integrates advanced imaging, precision targeting, and adaptive workflow for real-time lesion localization and lung diagnostics.

HealthtechMedical DevicesRobotics

Co-investorsChina Growth CapitalLYFE CapitalProsperity7 VenturesShangBay Capital LLC

Novel Materials

Advanced materials for auto and construction markets

Postmatespostmates.comAcquired

<UNKNOWN>

San Francisco, US

Bastian Lehman(Founder & CEO)Sam Street(Founder)inSean Plaice(Director)Bastian Lehmann(Executive Officer, Director)Lee Fixel(Director)

BoardScott Banister(Director)

Co-investorsAngelPadBrighter CapitalCrosslink CapitalEntrée CapitalExpansion Venture CapitalFirstMark Capital+31 more

Sustainable manufacturing

3D printing for industrial applications and heavy manufacturing

Sustainable transportation

Developers of advanced, low-emission railway propulsion platform

Vital Biosciences Inc.vitalbio.comin

VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.

BiotechDigital HealthMedical Devices

Vasu Nadella(Founder)in

Co-investorsNext VenturesInovia CapitalLachy GroomMarc BenioffNorthpond VenturesSam Altman+6 more

Waste-to-Value Chemicals

Producer of high-value chemicals through waste slag upcycling

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.